Placebo Nasal Spray - Placebo Nasal Spray for phobia, social

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 9 Jan 2025: Trial started, NCT06809179
  2. 5 Feb 2025: Trial registered, NCT06809179

The trials

NCT06809179: A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder

State
Completed
Phase
Phase 2
People
61 taking part
Started
9 Jan 2025
Primary completion
12 Jun 2026
Arms
Placebo Nasal Spray
Results
None posted
  1. 9 Jan 2025: Trial started
  2. 5 Feb 2025: Trial registered
  3. 26 Aug 2026: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.